XML 22 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
EQUITY INCENTIVE PLAN
6 Months Ended
Apr. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
EQUITY INCENTIVE PLAN
3.
EQUITY INCENTIVE PLAN
 
In March 2016, we adopted the Hurco Companies, Inc. 2016 Equity Incentive Plan (the “2016 Equity Plan”), which allows us to grant awards of stock options, stock appreciation rights (“SARs”), restricted stock, stock units and other stock-based awards. The 2016 Equity Plan replaced the 2008 Equity Incentive Plan (the “2008 Plan”) and is the only active plan under which equity awards may be made to our employees and non-employee directors. No further awards will be made under our 2008 Plan. The total number of shares of our common stock that may be issued pursuant to awards under the 2016 Equity Plan is 856,048, which included 386,048 shares remaining available for future grants under the 2008 Plan as of March 10, 2016, the date of shareholder approval of the 2016 Equity Plan.
 
The Compensation Committee of the Board of Directors has the authority to determine the officers, directors and key employees who will be granted awards; designate the number of shares subject to each award; determine the terms and conditions upon which awards will be granted; and prescribe the form and terms of award agreements. We have granted restricted shares under the 2016 Equity Plan which are currently outstanding, and we have granted stock options, restricted shares and performance shares under the 2008 Plan which are currently outstanding. No stock option may be exercised more than ten years after the date of grant or such shorter period as the Compensation Committee may determine at the date of grant. The market value of a share of our common stock, for purposes of the 2016 Equity Plan, is the closing sale price as reported by the Nasdaq Global Select Market on the date in question or, if not a trading day, on the last preceding trading date.
 
A summary of stock option activity for the six-month period ended April 30, 2016, is as follows:
 
 
 
Stock
Options
 
Weighted
Average
Exercise
Price
 
 
 
 
 
 
 
 
 
Outstanding at October 31, 2015
 
 
107,889
 
$
20.25
 
 
 
 
 
 
 
 
 
Options granted
 
 
 
 
 
Options exercised
 
 
 
 
 
Options cancelled
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at April 30, 2016
 
 
107,889
 
$
20.25
 
 
Summarized information about outstanding stock options as of April 30, 2016, that have already vested and those that are expected to vest, as well as stock options that are currently exercisable, are as follows:
 
 
 
Options Already
Vested and
Expected to Vest
 
Options Currently
Exercisable
 
 
 
 
 
 
 
 
 
Number of outstanding options
 
 
107,889
 
 
107,889
 
 
 
 
 
 
 
 
 
Weighted average remaining contractual life (years)
 
 
4.87
 
 
4.87
 
Weighted average exercise price per share
 
$
20.25
 
$
20.25
 
 
 
 
 
 
 
 
 
Intrinsic value of outstanding options
 
$
1,326,000
 
$
1,326,000
 
 
The intrinsic value of an outstanding stock option is calculated as the difference between the stock price as of April 30, 2016 and the exercise price of the option.
 
On January 4, 2016, the Compensation Committee approved a long-term incentive compensation arrangement for our executive officers in the form of restricted shares and performance shares awarded under the 2008 Plan. The awards were 25% time-based vesting and 75% performance-based vesting. The three-year performance period is fiscal 2016 through fiscal 2018.
 
On this date, the Compensation Committee granted a total of 17,684 shares of time-based restricted shares to our executive officers. The restricted shares vest in thirds over three years from the date of grant provided the recipient remains employed through that date. The grant date fair value of the restricted shares was based upon the closing sales price of our common stock on the date of grant which was $26.04 per share.
 
The Compensation Committee also granted a total target number of 24,023 performance shares to our executive officers designated as “Performance Shares – TSR”. The shares were weighted as 40% of the overall long-term incentive compensation arrangement and will vest and be paid based upon our total shareholder return of our common stock over a three-year period, relative to the total shareholder return of the companies in a specified peer group over that period. Participants will have the ability to earn between 50% of the target number of shares for achieving threshold performance and 200% of the target number of shares for achieving maximum performance. The fair value of the market-based performance shares was $30.67 per share and was calculated using the Monte Carlo approach.
 
The Compensation Committee also granted a total target number of 24,759 performance shares to our executive officers designated as “Performance Shares – ROIC”. These shares were weighted as 35% of the overall long-term incentive compensation arrangement and will vest and be paid based upon the achievement of pre-established goals related to our average return on invested capital over the three-year period. Participants will have the ability to earn between 50% of the target number of shares for achieving threshold performance and 200% of the target number of shares for achieving maximum performance. The grant date fair value of the ROIC performance shares was based on the closing sales price of our common stock on the grant date which was $26.04 per share.
 
On March 10, 2016, the Compensation Committee granted a total of 9,170 shares of time-based restricted stock under the 2016 Equity Plan to our non-employee directors. The restricted shares vest in full one year from the date of grant provided the recipient remains on the board of directors through that date. The grant date fair value of the restricted shares was based on the closing sales price of our common stock on the grant date which was $30.52 per share.
 
A reconciliation of the Company’s restricted stock activity and related information for the six-month period ended April 30, 2016 is as follows:
 
 
 
Number of
Shares
 
Weighted Average
Grant  Date
Fair Value
 
Unvested at October 31, 2015
 
 
98,799
 
$
28.89
 
Shares granted
 
 
75,636
 
 
28.05
 
Shares vested
 
 
(21,385)
 
 
27.63
 
Shares withheld
 
 
(5,700)
 
 
25.29
 
Unvested at April 30, 2016
 
 
147,350
 
$
28.78
 
 
During the first six months of fiscal 2016 and 2015, we recorded $759,000 and $569,000, respectively, as stock-based compensation expense related to grants under our equity plans. As of April 30, 2016, there was an estimated $2.9 million of total unrecognized stock-based compensation cost that we expect to recognize by the end of the first quarter of fiscal 2019.